Dr. Armstrong was formerly Vice President of Global External Research and Development and Chorus for Eli Lilly and Company.
In his previous role, Dr. Armstrong spearheaded a number of innovative initiatives at Lilly including the development of an integrated global network of R&D partnerships and the creation of external funding and molecule sourcing mechanisms to develop innovative drugs in the Chorus translational medicine engine. Dr. Armstrong also served as Vice President of Discovery Chemistry Research and Technologies at Lilly and prior to joining Lilly, he led Small Molecule Drug Discovery and Development at Amgen. He was also Associate Professor of Chemistry and Biochemistry at the University of California at Los Angeles. Dr. Armstrong received bachelor’s degrees in chemistry and biochemistry from the University of California at San Diego and a PhD in chemistry from Colorado State University.